Predictive Value of suPAR and hsCRP on Postoperative Mortality in Cardiac Surgery

Rigshospitalet

Status: Completed

Conditions: Biomarkers; Cardiac Surgical Procedures; Thoracic Surgery

Treatments: Other: Blood sampling

Study type: Observational

Funder types: Other

Identifiers

NCT04292249

H-18002379

Details and patient eligibility

About

This study aims to investigate whether preoperative soluble urokinase plasminogen activating receptor (suPAR) and High-sensitivity C-Reactive Protein (hsCRP) are independent markers of death after cardiac surgery. Further, to assess whether suPAR and hsCRP provides increased predictive accuracy of the clinical risk model EuroSCORE II. The purpose of the study is to gain knowledge on whether these inflammatory biomarkers might be able to reveal a pro-inflammatory disease state that represents a significant risk in patients undergoing cardiovascular surgery. Hence, these biomarkers may assist clinicians in selecting compassionate treatment for high risk patients.

Enrollment: 951 patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Planned elective on-pump cardiac surgery (isolated coronary artery bypass graft (CABG), single and multiple valvular procedures, combined CABG and valvular surgery, and others)
• Given informed consent on delivering a blood sample for the biobank.

Exclusion criteria

• Peroperatively cancelling the surgery
• Sudden change to off-pump coronary artery bypass (OPCAB) surgery
• Death prior to surgery
• Project blood samples not available.

Trial design

951 participants in 1 patient group

Elective on-pump cardiac surgery patients

Description:

Adult patients (≥18 years) undergoing elective on-pump cardiac surgery (isolated coronary artery bypass graft (CABG), single and multiple valvular procedures, combined CABG and valvular surgery, and others).

Treatment:

Other: Blood sampling